| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.982 | 0.002 | 0.988 | Non-steroidal antiinflammatory agent | 0.937 0.002 DBMET01002 0.988 0.001 DBMET01003 | DBMET01003 | |
| 0.808 | 0.014 | 0.808 | Antiinflammatory | 0.704 0.03 DBMET01002 0.802 0.015 DBMET01003 | ||
| 0.704 | 0.005 | 0.704 | Lipoxygenase inhibitor | 0.632 0.008 DBMET01002 0.533 0.015 DBMET01003 | ||
| 0.692 | 0.004 | 0.692 | Interleukin 1 antagonist | 0.183 0.041 DBMET01002 0.14 0.065 DBMET01003 | ||
| 0.614 | 0.004 | 0.837 | Cyclooxygenase inhibitor | 0.564 0.004 DBMET01002 0.837 0.003 DBMET01003 | DBMET01003 | |
| 0.598 | 0.004 | 0.788 | Cyclooxygenase 1 inhibitor | 0.596 0.004 DBMET01002 0.788 0.003 DBMET01003 | DBMET01003 | |
| 0.608 | 0.026 | 0.691 | Cyclophilin D inhibitor | 0.604 0.027 DBMET01002 0.691 0.015 DBMET01003 | DBMET01003 | |
| 0.562 | 0.004 | 0.562 | Interleukin 6 antagonist | 0.189 0.048 DBMET01002 0.199 0.041 DBMET01003 | ||
| 0.565 | 0.014 | 0.565 | Interleukin antagonist | 0.155 0.114 DBMET01002 | ||
| 0.505 | 0.027 | 0.505 | Histamine release inhibitor | 0.454 0.048 DBMET01002 | ||
| 0.478 | 0.004 | 0.738 | Cyclooxygenase 2 inhibitor | 0.426 0.005 DBMET01002 0.738 0.003 DBMET01003 | DBMET01003 | |
| 0.464 | 0.004 | 0.464 | Interleukin 1b antagonist | 0.099 0.082 DBMET01002 | ||
| 0.489 | 0.046 | 0.489 | Transcription factor NF kappa B inhibitor | 0.433 0.056 DBMET01002 0.349 0.077 DBMET01003 | ||
| 0.413 | 0.004 | 0.413 | Death-associated protein kinase 2 inhibitor | |||
| 0.39 | 0.018 | 0.39 | EphB2 antagonist | |||
| 0.4 | 0.039 | 0.403 | Nootropic | 0.334 0.059 DBMET01002 0.403 0.038 DBMET01003 | DBMET01003 | |
| 0.403 | 0.045 | 0.403 | 5 Hydroxytryptamine release stimulant | 0.256 0.086 DBMET01003 | ||
| 0.355 | 0.007 | 0.355 | Phospholipase A2 inhibitor | 0.309 0.012 DBMET01002 0.241 0.026 DBMET01003 | ||
| 0.351 | 0.005 | 0.421 | Prostaglandin antagonist | 0.35 0.005 DBMET01002 0.421 0.004 DBMET01003 | DBMET01003 | |
| 0.418 | 0.077 | 0.532 | Analgesic | 0.313 0.132 DBMET01002 0.532 0.04 DBMET01003 | DBMET01003 | |
| 0.404 | 0.064 | 0.44 | Antiobesity | 0.273 0.136 DBMET01002 0.44 0.052 DBMET01003 | DBMET01003 | |
| 0.395 | 0.062 | 0.395 | Toll-Like receptor agonist | 0.244 0.154 DBMET01002 0.343 0.085 DBMET01003 | ||
| 0.337 | 0.005 | 0.337 | MAP kinase 13 inhibitor | |||
| 0.322 | 0.005 | 0.322 | MAP kinase 12 inhibitor | |||
| 0.35 | 0.038 | 0.351 | Hypoglycemic | 0.323 0.045 DBMET01002 0.351 0.037 DBMET01003 | DBMET01003 | |
| 0.336 | 0.029 | 0.336 | Cyclic AMP phosphodiesterase inhibitor | 0.261 0.059 DBMET01002 | ||
| 0.374 | 0.071 | 0.374 | Toll-Like receptor 7 agonist | 0.221 0.177 DBMET01002 0.32 0.098 DBMET01003 | ||
| 0.303 | 0.003 | 0.362 | Prostaglandin D2 antagonist | 0.269 0.004 DBMET01002 0.362 0.003 DBMET01003 | DBMET01003 | |
| 0.388 | 0.119 | 0.401 | Apoptosis agonist | 0.401 0.113 DBMET01002 0.283 0.185 DBMET01003 | DBMET01002 | |
| 0.315 | 0.048 | 0.315 | Tumour necrosis factor alpha release inhibitor | |||
| 0.258 | 0.015 | 0.258 | 5-Lipoxygenase inhibitor | 0.2 0.024 DBMET01002 0.174 0.03 DBMET01003 | ||
| 0.251 | 0.012 | 0.251 | Antibacterial (Helicobacter pylori) | 0.2 0.022 DBMET01002 | ||
| 0.24 | 0.006 | 0.24 | Interleukin 8 antagonist | 0.156 0.03 DBMET01002 0.147 0.036 DBMET01003 | ||
| 0.238 | 0.005 | 0.238 | Aldose reductase inhibitor | 0.219 0.006 DBMET01002 0.218 0.006 DBMET01003 | ||
| 0.289 | 0.056 | 0.289 | Platelet antagonist | 0.224 0.085 DBMET01002 0.186 0.112 DBMET01003 | ||
| 0.261 | 0.044 | 0.261 | Peptidyltransferase inhibitor | 0.211 0.086 DBMET01003 | ||
| 0.222 | 0.013 | 0.222 | TIE antagonist | 0.088 0.051 DBMET01002 | ||
| 0.216 | 0.008 | 0.216 | MAP kinase 11 inhibitor | |||
| 0.217 | 0.012 | 0.217 | TIE-2 antagonist | 0.086 0.051 DBMET01002 | ||
| 0.2 | 0.004 | 0.2 | Thromboxane antagonist | 0.135 0.005 DBMET01002 0.197 0.004 DBMET01003 | ||
| 0.294 | 0.098 | 0.294 | Calcium channel activator | |||
| 0.19 | 0.003 | 0.249 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.249 0.003 DBMET01002 0.129 0.004 DBMET01003 | DBMET01002 | |
| 0.179 | 0.004 | 0.179 | Thromboxane A2 antagonist | 0.118 0.005 DBMET01002 0.175 0.004 DBMET01003 | ||
| 0.177 | 0.016 | 0.177 | Multidrug resistance-associated protein 1 inhibitor | 0.144 0.028 DBMET01002 0.113 0.057 DBMET01003 | ||
| 0.269 | 0.112 | 0.269 | Antithrombotic | 0.233 0.14 DBMET01002 0.261 0.117 DBMET01003 | ||
| 0.262 | 0.106 | 0.283 | Interleukin 2 agonist | 0.28 0.089 DBMET01002 0.283 0.087 DBMET01003 | DBMET01003 | |
| 0.26 | 0.118 | 0.291 | Sodium/bile acid cotransporter inhibitor | 0.27 0.108 DBMET01002 0.291 0.088 DBMET01003 | DBMET01003 | |
| 0.207 | 0.089 | 0.324 | Hypolipemic | 0.324 0.042 DBMET01002 0.264 0.062 DBMET01003 | DBMET01002 | |
| 0.152 | 0.042 | 0.152 | Histone deacetylase class III inhibitor | |||
| 0.129 | 0.025 | 0.221 | ABCA1 expression enhancer | 0.114 0.035 DBMET01002 0.221 0.008 DBMET01003 | DBMET01003 | |
| 0.108 | 0.005 | 0.147 | G protein-coupled receptor agonist | 0.038 0.027 DBMET01002 0.147 0.004 DBMET01003 | DBMET01003 | |
| 0.178 | 0.075 | 0.313 | Dual specificity phosphatase 3 inhibitor | 0.313 0.027 DBMET01002 0.236 0.045 DBMET01003 | DBMET01002 | |
| 0.217 | 0.122 | 0.435 | 5 Hydroxytryptamine uptake stimulant | 0.435 0.009 DBMET01002 0.217 0.122 DBMET01003 | DBMET01002 | |
| 0.137 | 0.048 | 0.146 | Papain-like protease (SARS coronavirus) inhibitor | 0.146 0.038 DBMET01002 0.137 0.048 DBMET01003 | DBMET01002 | |
| 0.094 | 0.007 | 0.148 | DNA helicase inhibitor | 0.104 0.005 DBMET01002 0.148 0.003 DBMET01003 | DBMET01003 | |
| 0.165 | 0.08 | 0.295 | Dual specificity phosphatase inhibitor | 0.295 0.029 DBMET01002 0.211 0.05 DBMET01003 | DBMET01002 | |
| 0.113 | 0.03 | 0.113 | MAP kinase 14 inhibitor | |||
| 0.087 | 0.011 | 0.087 | H+/K+-transporting ATPase inhibitor | |||
| 0.078 | 0.003 | 0.103 | Retinoid X receptor antagonist | 0.103 0.002 DBMET01002 0.096 0.002 DBMET01003 | DBMET01002 | |
| 0.113 | 0.039 | 0.113 | NMDA receptor antagonist | |||
| 0.075 | 0.006 | 0.075 | Sirtuin 2 inhibitor | |||
| 0.096 | 0.033 | 0.096 | Thioredoxin reductase inhibitor | 0.083 0.053 DBMET01002 0.086 0.048 DBMET01003 | ||
| 0.123 | 0.06 | 0.123 | Monophenol monooxygenase inhibitor | |||
| 0.064 | 0.003 | 0.093 | Retinoid X alpha receptor antagonist | 0.093 0.002 DBMET01002 0.086 0.002 DBMET01003 | DBMET01002 | |
| 0.08 | 0.023 | 0.086 | Nitric oxide donor | 0.057 0.054 DBMET01002 0.086 0.017 DBMET01003 | DBMET01003 | |
| 0.133 | 0.077 | 0.133 | Cytokine production inhibitor | |||
| 0.088 | 0.035 | 0.149 | Peroxisome proliferator-activated receptor gamma agonist | 0.149 0.013 DBMET01002 0.104 0.026 DBMET01003 | DBMET01002 | |
| 0.089 | 0.038 | 0.089 | Histone deacetylase SIRT2 inhibitor | |||
| 0.061 | 0.019 | 0.061 | Carbonic anhydrase IV inhibitor | |||
| 0.059 | 0.02 | 0.059 | Neurokinin 3 antagonist | |||
| 0.062 | 0.025 | 0.062 | Thromboxane synthase inhibitor | 0.052 0.043 DBMET01002 | ||
| 0.131 | 0.095 | 0.34 | Insulin secretagoues | 0.16 0.064 DBMET01002 0.34 0.009 DBMET01003 | DBMET01003 | |
| 0.087 | 0.053 | 0.087 | Vanilloid agonist | |||
| 0.059 | 0.029 | 0.059 | Leukotriene B4 antagonist | |||
| 0.128 | 0.099 | 0.128 | Hemostatic | 0.12 0.113 DBMET01003 | ||
| 0.04 | 0.014 | 0.084 | Prostaglandin agonist | 0.084 0.006 DBMET01002 0.03 0.023 DBMET01003 | DBMET01002 | |
| 0.071 | 0.047 | 0.071 | Amidase inhibitor | |||
| 0.087 | 0.064 | 0.093 | Triose-phosphate isomerase inhibitor | 0.093 0.056 DBMET01002 0.087 0.064 DBMET01003 | DBMET01002 | |
| 0.077 | 0.056 | 0.077 | Viral attachment inhibitor | |||
| 0.064 | 0.043 | 0.064 | Transcription factor RelA inhibitor | |||
| 0.17 | 0.149 | 0.17 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.059 | 0.042 | 0.106 | Prostaglandin EP2 antagonist | 0.106 0.017 DBMET01002 0.089 0.023 DBMET01003 | DBMET01002 | |
| 0.031 | 0.019 | 0.031 | Glucagon receptor antagonist | |||
| 0.062 | 0.052 | 0.062 | Leukotriene synthesis inhibitor | |||
| 0.083 | 0.077 | 0.086 | Uric acid excretion stimulant | 0.086 0.072 DBMET01002 | DBMET01002 | |
| 0.038 | 0.033 | 0.038 | Neurokinin 2 antagonist | |||
| 0.107 | 0.101 | 0.127 | Sphingosine 1-phosphate receptor 4 antagonist | 0.127 0.06 DBMET01003 | DBMET01003 | |
| 0.044 | 0.038 | 0.044 | Dopamine transporter inhibitor | |||
| 0.032 | 0.026 | 0.048 | Peroxisome proliferator-activated receptor delta antagonist | 0.048 0.01 DBMET01002 0.04 0.015 DBMET01003 | DBMET01002 | |
| 0.029 | 0.025 | 0.029 | HCV NS5B polymerase inhibitor | |||
| 0.038 | 0.034 | 0.297 | Liver X receptor alpha agonist | 0.047 0.022 DBMET01002 0.297 0.003 DBMET01003 | DBMET01003 | |
| 0.122 | 0.12 | 0.175 | Sphingosine 1-phosphate receptor 5 antagonist | 0.127 0.108 DBMET01002 0.175 0.028 DBMET01003 | DBMET01003 | |
| 0.043 | 0.041 | 0.065 | Mineralocorticoid receptor antagonist | 0.055 0.024 DBMET01002 0.065 0.016 DBMET01003 | DBMET01003 | |
| 0.015 | 0.014 | 0.034 | G-protein-coupled receptor 120 agonist | 0.034 0.005 DBMET01002 0.017 0.012 DBMET01003 | DBMET01002 | |
| 0.026 | 0.026 | 0.114 | Liver X receptor alpha antagonist | 0.029 0.021 DBMET01002 0.114 0.004 DBMET01003 | DBMET01003 | |
| 0.043 | 0.042 | 0.052 | Carnitine palmitoyltransferase 1B inhibitor | 0.043 0.042 DBMET01002 0.052 0.026 DBMET01003 | DBMET01003 | |
| 0.093 | 0.092 | 0.127 | DOPA decarboxylase inhibitor | 0.127 0.038 DBMET01002 0.102 0.072 DBMET01003 | DBMET01002 | |
| 0.098 | 0.098 | 0.181 | Amylase inhibitor | 0.181 0.051 DBMET01002 | DBMET01002 | |
| 0.019 | 0.02 | 0.023 | Glutamate (mGluR1a) agonist | 0.023 0.015 DBMET01002 | DBMET01002 | |
| 0.031 | 0.032 | 0.035 | HMG CoA reductase inhibitor | 0.035 0.022 DBMET01002 0.031 0.03 DBMET01003 | DBMET01002 | |
| 0.026 | 0.028 | 0.164 | Liver X receptor antagonist | 0.029 0.025 DBMET01002 0.164 0.004 DBMET01003 | DBMET01003 | |
| 0.015 | 0.02 | 0.019 | CXC chemokine 5 receptor antagonist | 0.019 0.01 DBMET01003 | DBMET01003 | |
| 0.037 | 0.043 | 0.064 | Sphingosine 1-phosphate receptor agonist | 0.064 0.014 DBMET01002 0.051 0.024 DBMET01003 | DBMET01002 | |
| 0.018 | 0.024 | 0.034 | Prostaglandin E2 agonist | 0.034 0.009 DBMET01002 | DBMET01002 | |
| 0.195 | 0.203 | 0.22 | Immunosuppressant | 0.22 0.176 DBMET01002 | DBMET01002 | |
| 0.026 | 0.035 | 0.037 | Retinoid X receptor agonist | 0.037 0.024 DBMET01002 | DBMET01002 | |
| 0.012 | 0.022 | 0.017 | Free fatty acid receptor 1 agonist | 0.017 0.013 DBMET01003 | DBMET01003 | |
| 0.044 | 0.055 | 0.063 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.063 0.026 DBMET01003 | DBMET01003 | |
| 0.01 | 0.026 | 0.028 | Thyroid hormone alpha antagonist | 0.015 0.011 DBMET01002 0.028 0.005 DBMET01003 | DBMET01003 | |
| 0.013 | 0.031 | 0.039 | Prostaglandin EP2 agonist | 0.039 0.009 DBMET01002 | DBMET01002 | |
| 0.019 | 0.037 | 0.139 | Liver X receptor beta antagonist | 0.139 0.003 DBMET01003 | DBMET01003 | |
| 0.028 | 0.048 | 0.064 | Secretase gamma inhibitor | 0.047 0.027 DBMET01002 0.064 0.016 DBMET01003 | DBMET01003 | |
| 0.113 | 0.136 | 0.167 | Arachidonic acid antagonist | 0.167 0.068 DBMET01002 | DBMET01002 | |
| 0.032 | 0.056 | 0.049 | Cannabinoid CB2 receptor antagonist | 0.049 0.038 DBMET01003 | DBMET01003 | |
| 0.023 | 0.049 | 0.035 | Free fatty acid receptor 1 antagonist | 0.035 0.021 DBMET01002 | DBMET01002 | |
| 0.059 | 0.089 | 0.093 | Peroxisome proliferator-activated receptor gamma antagonist | 0.093 0.02 DBMET01002 0.076 0.04 DBMET01003 | DBMET01002 | |
| 0.029 | 0.059 | 0.046 | Sphingosine 1-phosphate receptor 1 agonist | 0.046 0.024 DBMET01002 | DBMET01002 | |
| 0.064 | 0.096 | 0.081 | Sphingosine 1-phosphate receptor antagonist | 0.081 0.043 DBMET01003 | DBMET01003 | |
| 0.019 | 0.059 | 0.207 | Liver X receptor beta agonist | 0.207 0.003 DBMET01003 | DBMET01003 | |
| 0.053 | 0.093 | 0.072 | HIV-1 integrase inhibitor | 0.072 0.045 DBMET01002 0.067 0.053 DBMET01003 | DBMET01002 | |
| 0.029 | 0.07 | 0.175 | Liver X receptor agonist | 0.175 0.004 DBMET01003 | DBMET01003 | |
| 0.009 | 0.051 | 0.034 | Prostaglandin H2 antagonist | 0.034 0.01 DBMET01002 0.031 0.012 DBMET01003 | DBMET01002 | |
| 0.043 | 0.092 | 0.066 | Prostaglandin F2 alpha antagonist | 0.059 0.048 DBMET01002 0.066 0.037 DBMET01003 | DBMET01003 | |
| 0.07 | 0.119 | 0.095 | Ferrochelatase inhibitor | 0.095 0.076 DBMET01002 | DBMET01002 | |
| 0.04 | 0.093 | 0.05 | Sphingosine 1-phosphate receptor 5 agonist | 0.05 0.046 DBMET01002 | DBMET01002 | |
| 0.055 | 0.11 | 0.07 | MDM2 inhibitor | 0.07 0.038 DBMET01003 | DBMET01003 | |
| 0.027 | 0.084 | 0.104 | Beta tubulin antagonist | 0.104 0.021 DBMET01002 | DBMET01002 | |
| 0.096 | 0.154 | 0.203 | Mcl-1 antagonist | 0.203 0.054 DBMET01002 0.139 0.101 DBMET01003 | DBMET01002 | |
| 0.019 | 0.079 | 0.047 | Urate transporter 1 inhibitor | 0.047 0.02 DBMET01002 | DBMET01002 | |
| 0.038 | 0.098 | 0.079 | Sphingosine 1-phosphate receptor 4 agonist | 0.079 0.037 DBMET01002 | DBMET01002 | |
| 0.05 | 0.112 | 0.074 | CDC25A inhibitor | 0.074 0.051 DBMET01002 | DBMET01002 | |
| 0.058 | 0.125 | 0.077 | Glutathione S-transferase inhibitor | 0.074 0.071 DBMET01002 0.077 0.067 DBMET01003 | DBMET01003 | |
| 0.07 | 0.139 | 0.17 | AMP-activated protein kinase stimulant | 0.144 0.032 DBMET01002 0.17 0.017 DBMET01003 | DBMET01003 | |
| 0.013 | 0.082 | 0.038 | Peroxisome proliferator-activated receptor delta agonist | 0.038 0.019 DBMET01002 | DBMET01002 | |
| 0.012 | 0.083 | 0.041 | Progesterone antagonist | 0.041 0.022 DBMET01002 | DBMET01002 | |
| 0.147 | 0.224 | 0.287 | Thioredoxin glutathione reductase inhibitor | 0.249 0.134 DBMET01002 0.287 0.11 DBMET01003 | DBMET01003 | |
| 0.018 | 0.096 | 0.066 | Peroxisome proliferator-activated receptor alpha agonist | 0.066 0.024 DBMET01002 | DBMET01002 | |
| 0.028 | 0.117 | 0.099 | Aldosterone antagonist | 0.057 0.022 DBMET01002 0.099 0.008 DBMET01003 | DBMET01003 | |
| 0.008 | 0.105 | 0.029 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.029 0.018 DBMET01003 | DBMET01003 | |
| 0.042 | 0.143 | 0.064 | Bcl-xL inhibitor | 0.064 0.029 DBMET01002 0.057 0.051 DBMET01003 | DBMET01002 | |
| 0.021 | 0.123 | 0.073 | Alpha tubulin antagonist | 0.073 0.023 DBMET01002 | DBMET01002 | |
| 0.033 | 0.136 | 0.062 | Alpha 1b adrenoreceptor agonist | 0.062 0.017 DBMET01002 0.049 0.037 DBMET01003 | DBMET01002 | |
| 0.082 | 0.185 | 0.126 | Protein-tyrosine phosphatase inhibitor | 0.126 0.106 DBMET01002 | DBMET01002 | |
| 0.033 | 0.152 | 0.053 | Sphingosine 1-phosphate receptor 1 antagonist | 0.053 0.045 DBMET01003 | DBMET01003 | |
| 0.147 | 0.267 | 0.282 | Tyrosine 3 hydroxylase inhibitor | 0.282 0.043 DBMET01003 | DBMET01003 | |
| 0.033 | 0.154 | 0.075 | NMDA receptor agonist | 0.075 0.032 DBMET01002 | DBMET01002 | |
| 0.045 | 0.169 | 0.093 | Keratolytic | 0.093 0.035 DBMET01002 0.092 0.036 DBMET01003 | DBMET01002 | |
| 0.031 | 0.167 | 0.069 | Elastase 1 inhibitor | 0.069 0.048 DBMET01003 | DBMET01003 | |
| 0.046 | 0.184 | 0.082 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.082 0.061 DBMET01002 0.075 0.073 DBMET01003 | DBMET01002 | |
| 0.091 | 0.231 | 0.137 | Interferon gamma antagonist | 0.137 0.098 DBMET01003 | DBMET01003 | |
| 0.077 | 0.227 | 0.114 | Mannose-6-phosphate isomerase inhibitor | 0.114 0.111 DBMET01002 | DBMET01002 | |
| 0.082 | 0.236 | 0.169 | Insulin sensitizer | 0.169 0.108 DBMET01002 0.165 0.114 DBMET01003 | DBMET01002 | |
| 0.062 | 0.219 | 0.1 | CDC-like kinase 3 inhibitor | 0.1 0.079 DBMET01002 | DBMET01002 | |
| 0.018 | 0.182 | 0.076 | NMDA receptor glycine site agonist | 0.076 0.031 DBMET01002 | DBMET01002 | |
| 0.064 | 0.232 | 0.118 | Histone deacetylase SIRT1 inhibitor | 0.118 0.094 DBMET01003 | DBMET01003 | |
| 0.021 | 0.208 | 0.05 | Cathepsin F inhibitor | 0.05 0.013 DBMET01003 | DBMET01003 | |
| 0.068 | 0.257 | 0.148 | Amyloid beta precursor protein antagonist | 0.148 0.103 DBMET01002 | DBMET01002 | |
| 0.071 | 0.282 | 0.119 | Sphingosine 1-phosphate receptor 2 antagonist | 0.119 0.099 DBMET01003 | DBMET01003 | |
| 0.106 | 0.321 | 0.158 | Heat shock protein 70 antagonist | 0.158 0.03 DBMET01002 | DBMET01002 | |
| 0.077 | 0.301 | 0.154 | Pregnane X receptor agonist | 0.154 0.046 DBMET01003 | DBMET01003 | |
| 0.034 | 0.282 | 0.102 | Tubulin antagonist | 0.102 0.099 DBMET01002 | DBMET01002 | |
| 0.123 | 0.377 | 0.179 | 5 Hydroxytryptamine 3E antagonist | 0.179 0.107 DBMET01002 | DBMET01002 | |
| 0.108 | 0.364 | 0.23 | Insulysin inhibitor | 0.23 0.117 DBMET01003 | DBMET01003 | |
| 0.046 | 0.317 | 0.163 | NADPH oxidase inhibitor | 0.163 0.047 DBMET01002 | DBMET01002 | |
| 0.04 | 0.319 | 0.096 | Lanosterol 14 alpha demethylase inhibitor | 0.096 0.061 DBMET01003 | DBMET01003 | |
| 0.047 | 0.332 | 0.14 | TRKC antagonist | 0.14 0.11 DBMET01002 | DBMET01002 | |
| 0.038 | 0.37 | 0.219 | Anesthetic general | 0.219 0.065 DBMET01002 | DBMET01002 | |
| 0.031 | 0.394 | 0.134 | Pyruvate kinase inhibitor | 0.134 0.131 DBMET01002 | DBMET01002 | |
| 0.015 | 0.386 | 0.054 | Acetyl-CoA transferase 2 inhibitor | 0.054 0.045 DBMET01002 | DBMET01002 | |
| 0.052 | 0.437 | 0.231 | Thyroid hormone antagonist | 0.231 0.136 DBMET01003 | DBMET01003 | |
| 0.052 | 0.441 | 0.217 | Thyroid hormone beta antagonist | 0.217 0.14 DBMET01003 | DBMET01003 | |
| 0.083 | 0.592 | 0.278 | Caspase 9 stimulant | 0.278 0.218 DBMET01002 | DBMET01002 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |